Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis.

OBJECTIVE To perform a meta-analysis of case-control studies that addressed whether prior oral contraceptive (OC) use is associated with premenopausal breast cancer. METHODS We searched the MEDLINE and PubMed databases and bibliography reviews to identify case-control studies of OCs and premenopausal breast cancer published in or after 1980. Search terms used included breast neoplasms, oral contraceptives, contraceptive agents, and case-control studies. Studies reported in all languages were included. Thirty-four studies were identified that met inclusion criteria. Two reviewers extracted data from original research articles or additional data provided by study authors. We used the DerSimonian-Laird method to compute pooled odds ratios (ORs) and confidence intervals (CIs) and the Mantel-Haenszel test to assess association between OC use and cancer. RESULTS Use of OCs was associated with an increased risk of premenopausal breast cancer in general (OR, 1.19; 95% CI, 1.09-1.29) and across various patterns of OC use. Among studies that provided data on nulliparous and parous women separately, OC use was associated with breast cancer risk in both parous (OR, 1.29; 95% CI, 1.20-1.40) and nulliparous (OR, 1.24; 95% CI, 0.92-1.67) women. Longer duration of use did not substantially alter risk in nulliparous women (OR, 1.29; 95% CI, 0.85-1.96). Among parous women, the association was stronger when OCs were used before first full-term pregnancy (FFTP) (OR, 1.44; 95% CI, 1.28-1.62) than after FFTP (OR, 1.15; 95% CI, 1.06-1.26). The association between OC use and breast cancer risk was greatest for parous women who used OCs 4 or more years before FFTP (OR, 1.52; 95% CI, 1.26-1.82). CONCLUSION Use of OCs is associated with an increased risk of premenopausal breast cancer, especially with use before FFTP in parous women.

[1]  Petra M. Casey,et al.  Oral contraceptive use and risk of breast cancer. , 2008, Mayo Clinic proceedings.

[2]  D. Preston,et al.  Male breast cancer incidence among atomic bomb survivors. , 2005, Journal of the National Cancer Institute.

[3]  A. Jemal,et al.  Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.

[4]  J. Christ Seventh day adventists. , 2005, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[5]  John Robbins,et al.  National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section , 2004, BMJ : British Medical Journal.

[6]  B. Henderson,et al.  Use of oral contraceptives and risk of breast cancer in young women , 1998, Breast Cancer Research and Treatment.

[7]  G. Giles,et al.  Breast cancer in Australian women under the age of 40 , 1998, Cancer Causes & Control.

[8]  W. Willett,et al.  Recent oral contraceptive use and risk of breast cancer (United States) , 1996, Cancer Causes & Control.

[9]  S. Shapiro,et al.  Oral contraceptive use and breast cancer risk among African-American women , 1995, Cancer Causes & Control.

[10]  R. Gallagher,et al.  Noncontraceptive hormone use and risk of breast cancer , 1992, Cancer Causes & Control.

[11]  S. Duffy,et al.  Risk factors for breast cancer by age and menopausal status: a case-control study in Singapore , 1992, Cancer Causes & Control.

[12]  J. Manson,et al.  A prospective study of oral contraceptive use and risk of breast cancer (Nurses' Health Study, United States) , 2004, Cancer Causes & Control.

[13]  R. Goldbohm,et al.  Exogenous hormone use and the risk of postmenopausal breast cancer: results from the Netherlands Cohort Study , 1996, Cancer Causes & Control.

[14]  R. Langer,et al.  Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. , 2003, JAMA.

[15]  V. Dumeaux,et al.  Breast cancer and specific types of oral contraceptives: A large Norwegian cohort study , 2003, International journal of cancer.

[16]  D. Brogan,et al.  Hormonal content and potency of oral contraceptives and breast cancer risk among young women , 2003, British Journal of Cancer.

[17]  B. Friedenson Oral contraceptives and the risk of breast cancer. , 2002, The New England journal of medicine.

[18]  H. Adami,et al.  Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women's Lifestyle and Health Cohort Study. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  R. Millikan,et al.  Oral contraceptives and breast cancer among African-american women and white women. , 2001, Journal of the National Medical Association.

[20]  W. Zheng,et al.  Abortion history and breast cancer risk: Results from the Shanghai breast cancer study , 2001, International journal of cancer.

[21]  E. Tomasi,et al.  [Oral contraceptives and breast cancer: a case-control study] , 2001 .

[22]  A. Barros,et al.  Contraceptivos orais e câncer de mama: estudo de casos e controles* Oral contraceptive and breast cancer: a case- control study , 2001 .

[23]  J. Russo,et al.  Cancer risk related to mammary gland structure and development , 2001, Microscopy research and technique.

[24]  A. Barros,et al.  [Oral contraceptive and breast cancer: a case-control study]. , 2001, Revista de saude publica.

[25]  D. Grabrick,et al.  Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer. , 2000, JAMA.

[26]  S. Shapiro,et al.  Risk of breast cancer in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives. , 2000, American journal of epidemiology.

[27]  J. Stanford,et al.  Postfertilization effects of oral contraceptives and their relationship to informed consent. , 2000, Archives of family medicine.

[28]  D. Grobbee,et al.  Long‐term oral contraceptive use increases breast cancer risk in women over 55 years of age: The DOM cohort , 2000, International journal of cancer.

[29]  M. Pike,et al.  Breast cancer and oral contraceptive use in Asian-American women. , 1999, American journal of epidemiology.

[30]  C. la Vecchia,et al.  Risk factors for breast cancer in women under 40 years. , 1999, European journal of cancer.

[31]  R. Millikan,et al.  Adolescent reproductive events and subsequent breast cancer risk. , 1999, American journal of public health.

[32]  W. Thompson,et al.  Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[33]  Valerie Beral,et al.  Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study , 1999, BMJ.

[34]  L. Tyrer Introduction of the pill and its impact. , 1999, Contraception.

[35]  M. Rosenberg,et al.  Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons. , 1998, American journal of obstetrics and gynecology.

[36]  Chiun-Sheng Huang,et al.  Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives , 1998, International journal of cancer.

[37]  L. Tryggvadottir,et al.  Oral contraceptive use at a young age and the risk of breast cancer: an Icelandic, population-based cohort study of the effect of birth year. , 1997, British Journal of Cancer.

[38]  J. Stanford,et al.  Oral contraceptive use and risk of breast cancer in middle-aged women. , 1996, American journal of epidemiology.

[39]  Julian Peto,et al.  Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies , 1996, The Lancet.

[40]  P. Sismondi,et al.  Oral Contraceptive Use and Breast Cancer Risk in Areas with Different Incidence , 1996, Annals of the New York Academy of Sciences.

[41]  M. C. Leske,et al.  Breast cancer and hormonal contraceptives: further results , 1996 .

[42]  Karen Steindorf,et al.  Results of a case-control study on previous infections and other risk factors for ischemic cerebrovascular diseases: attributable and absolute risks , 1996, GMDS.

[43]  S. Shapiro,et al.  Case-control study of oral contraceptive use and risk of breast cancer. , 1996, American journal of epidemiology.

[44]  D. Amadori,et al.  Oral contraceptives and breast cancer: A cooperative Italian study , 2006, International journal of cancer.

[45]  P. Boyle,et al.  Breast‐cancer risk and oral contraceptive use in slovenian women aged 25 to 54 , 1995, International journal of cancer.

[46]  R. Hoover,et al.  Oral contraceptives and breast cancer risk among younger women. , 1995, Journal of the National Cancer Institute.

[47]  H. Gobbi,et al.  A case-control study of risk factors for breast cancer in Brazil, 1978-1987. , 1995, International journal of epidemiology.

[48]  C. Paul,et al.  Depot medroxyprogesterone acetate and breast cancer. A pooled analysis of the World Health Organization and New Zealand studies. , 1995, JAMA.

[49]  D. Torgerson Risk factors for breast cancer , 1994, BMJ.

[50]  F. Leeuwen,et al.  Oral contraceptives and risk of breast cancer in women aged 20-54 years , 1994, The Lancet.

[51]  R. Mayberry Age-specific patterns of association between breast cancer and risk factors in black women, ages 20 to 39 and 40 to 54. , 1994, Annals of epidemiology.

[52]  N. Weiss,et al.  Breast cancer among young U.S. women in relation to oral contraceptive use. , 1994, Journal of the National Cancer Institute.

[53]  W. Willett,et al.  Lactation and a reduced risk of premenopausal breast cancer. , 1994, The New England journal of medicine.

[54]  M. Thun,et al.  Family history, age, and risk of fatal breast cancer. , 1993, American journal of epidemiology.

[55]  D B Thomas,et al.  Comparison of recalled and validated oral contraceptive histories. , 1993, American journal of epidemiology.

[56]  A. Maclennan,et al.  Inhibin and relaxin concentrations in early singleton, multiple, and failing pregnancy: Relationship to gonadotropin and steroid profiles , 1993, Fertility and sterility.

[57]  C. la Vecchia,et al.  Oral contraceptives and breast cancer in northern Italy. Final report from a case-control study. , 1993, British Journal of Cancer.

[58]  J W Overstreet,et al.  Enhanced ovarian steroid secretion before implantation in early human pregnancy. , 1993, The Journal of clinical endocrinology and metabolism.

[59]  T. Heeren,et al.  Breast cancer in mothers prescribed diethylstilbestrol in pregnancy: Further follow‐up , 1993, JAMA.

[60]  C. Macera,et al.  Oral contraceptive use and breast cancer in Indonesia. , 1993, Contraception.

[61]  M. Szklo,et al.  Consistent lack of association between breast cancer and oral contraceptives using either hospital or neighborhood controls. , 1993, Preventive medicine.

[62]  J. Nuovo,et al.  Do Oral Contraceptive Agents Affect The Risk Of Breast Cancer? A Meta-Analysis Of The Case-Control Reports , 1993, The Journal of the American Board of Family Medicine.

[63]  N. Weiss,et al.  Oral contraceptives in relation to breast cancer. , 1993, Epidemiologic reviews.

[64]  S. Shapiro,et al.  A case-control study of the risk of breast cancer in relation to oral contraceptive use. , 1992, American journal of epidemiology.

[65]  L. Rushton,et al.  Oral contraceptive use and breast cancer risk: A meta‐analysis of variations with age at diagnosis, parity and total duration of oral contraceptive use , 1992, British journal of obstetrics and gynaecology.

[66]  A. Miller,et al.  Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[67]  B. Henderson,et al.  A case-control study of breast cancer in Tianjin, China. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[68]  W. Thompson,et al.  Oral Contraceptives and Premenopausal Bilateral Breast Cancer: A Case-Control Study , 1992, Epidemiology.

[69]  M. Ewertz Oral contraceptives and breast cancer risk in Denmark. , 1992, European journal of cancer.

[70]  V. Miller,et al.  Progestins and breast cancer: an epidemiologic review. , 1992, Fertility and sterility.

[71]  J. Ranstam,et al.  Survival in breast cancer and age at start of oral contraceptive usage. , 1991, Anticancer research.

[72]  M. Gerber,et al.  The pattern of risk factors for breast cancer in a southern France population. Interest for a stratified analysis by age at diagnosis. , 1991, British Journal of Cancer.

[73]  M. Fernö,et al.  Her-2/neu and INT2 proto-oncogene amplification in malignant breast tumors in relation to reproductive factors and exposure to exogenous hormones. , 1991, Journal of the National Cancer Institute.

[74]  M. C. Leske,et al.  Breast cancer risk and oral contraceptive use: results from a large case-control study. , 1991, Epidemiology.

[75]  D. Thomas,et al.  Oral contraceptives and breast cancer: review of the epidemiologic literature. , 1991, Contraception.

[76]  G. Breart,et al.  Oral contraceptives and breast cancer: a French case-control study. , 1991, International journal of epidemiology.

[77]  M. Fernö,et al.  Proliferation and DNA ploidy in malignant breast tumors in relation to early oral contraceptive use and early abortions , 1991, Cancer.

[78]  Joyce A. Cramer,et al.  Patient Compliance in Medical Practice and Clinical Trials , 1991 .

[79]  V. Beral,et al.  Age‐specific differences in the relationship between oral contraceptive use and breast cancer , 1990, Obstetrics and gynecology.

[80]  M. Fernö,et al.  Early oral contraceptive use and premenopausal breast cancer--a review of studies performed in southern Sweden. , 1991, Cancer Detection and Prevention.

[81]  M. Delgado-Rodríguez,et al.  Oral contraceptives and breast cancer. A meta-analysis. , 1991, Revue d'epidemiologie et de sante publique.

[82]  G. Colditz,et al.  Oral contraceptives and breast cancer review and meta‐analysis , 1990, Cancer.

[83]  M. Pike,et al.  Increased cell division as a cause of human cancer. , 1990, Cancer research.

[84]  A. Miller,et al.  Canadian National Breast Screening Study. , 1990, AJR. American journal of roentgenology.

[85]  B. Hulka,et al.  Oral contraceptives and breast cancer: A case‐control study with hospital and community controls , 1990, Obstetrics and gynecology.

[86]  B. Ames,et al.  Too many rodent carcinogens: mitogenesis increases mutagenesis. , 1990, Science.

[87]  L. Ellwein,et al.  Cell proliferation in carcinogenesis. , 1990, Science.

[88]  The Who Collaborative Study of Neoplasia and Steroid Contraceptives Breast cancer and combined oral contraceptives: results from a multinational study , 1990 .

[89]  K. McPherson,et al.  Oral contraceptive use influences resting breast proliferation. , 1989, Human pathology.

[90]  M. L. Balassone,et al.  Risk of contraceptive discontinuation among adolescents. , 1989, Journal of adolescent health care : official publication of the Society for Adolescent Medicine.

[91]  W. Willett,et al.  Prospective study of oral contraceptive use and risk of breast cancer in women. , 1989, Journal of the National Cancer Institute.

[92]  H. Adami,et al.  Oral contraceptive use and premenopausal breast cancer in Sweden and Norway: possible effects of different pattern of use. , 1989, International journal of epidemiology.

[93]  R. Hoover,et al.  Oral contraceptives and breast cancer: results from an expanded case-control study. , 1989, British Journal of Cancer.

[94]  W. L. Beeson,et al.  Prospective study of exogenous hormone use and breast cancer in seventh‐day adventists , 1989, Cancer.

[95]  C Bain,et al.  Breast cancer and breastfeeding: results from an Australian case-control study. , 1989, American journal of epidemiology.

[96]  J. Ranstam,et al.  Early oral contraceptive use and breast cancer among premenopausal women: final report from a study in southern Sweden. , 1989, Journal of the National Cancer Institute.

[97]  Uk National Case-Control Study Group ORAL CONTRACEPTIVE USE AND BREAST CANCER RISK IN YOUNG WOMEN , 1989, The Lancet.

[98]  Uknationalcasecontrolstudygro ORAL CONTRACEPTIVE USE AND BREAST CANCER RISK IN YOUNG WOMEN , 1989 .

[99]  K. McPherson,et al.  Oral contraceptives and breast cancer: latest findings in a large cohort study. , 1989, British Journal of Cancer.

[100]  S. Shapiro,et al.  Breast cancer before age 45 and oral contraceptive use: new findings. , 1989, American journal of epidemiology.

[101]  T. Rohan,et al.  Oral contraceptive agents and breast cancer: a population‐based case‐control study , 1988, The Medical journal of Australia.

[102]  P. Hannaford,et al.  Breast cancer and the pill--a further report from the Royal College of General Practitioners' oral contraception study. , 1988, British Journal of Cancer.

[103]  J. Schlesselman,et al.  Oral contraceptives and premenopausal breast cancer in nulliparous women. , 1988, Contraception.

[104]  B. Henderson,et al.  Risk factors for breast cancer in Chinese women in Shanghai. , 1988, Cancer research.

[105]  U. Pastorino,et al.  The relationship of dietary intake and serum levels of retinol and beta‐carotene with breast cancer. Results of a case‐control study , 1988, Cancer.

[106]  K. Kosmelj,et al.  A case-control study of breast cancer in relation to oral contraceptive use in Slovenia. , 1988, Neoplasma.

[107]  L. Rosero-Bixby,et al.  A case-control study of breast cancer and hormonal contraception in Costa Rica. , 1987, Journal of the National Cancer Institute.

[108]  R. Doll,et al.  Early oral contraceptive use and breast cancer: results of another case-control study. , 1987, British Journal of Cancer.

[109]  A. Huggins,et al.  Risk factors for breast cancer with applications to selection for the prevalence screen. , 1987, Journal of epidemiology and community health.

[110]  S. Shapiro,et al.  Oral-Contraceptive Use and the Risk of Breast Cancer , 1987 .

[111]  P. Wingo,et al.  Oral-contraceptive use and the risk of breast cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. , 1987, The New England journal of medicine.

[112]  A. Molinolo,et al.  Induction of mammary adenocarcinomas by medroxyprogesterone acetate in BALB/c female mice. , 1986, Cancer letters.

[113]  H. Adami,et al.  ORAL CONTRACEPTIVE USE AND BREAST CANCER IN YOUNG WOMEN A Joint National Case-control Study in Sweden and Norway , 1986, The Lancet.

[114]  D. Thomas,et al.  Evidence for a protective effect of lactation on risk of breast cancer in young women. Results from a case-control study. , 1986, American journal of epidemiology.

[115]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[116]  G. Berry,et al.  A case–control study of breast cancer in relation to the use of steroid contraceptive agents , 1986, The Medical journal of Australia.

[117]  L. Kolonel,et al.  The association of replacement estrogens with breast cancer , 1986, International journal of cancer.

[118]  J. Elwood,et al.  Childhood and recent eating patterns and risk of breast cancer. , 1986, Cancer detection and prevention.

[119]  Another Look at the Pill and Breast Cancer , 1985, The Lancet.

[120]  A. Kramar,et al.  [A study on the association between the use of oral contraception and cancer of the breast or cervix: preliminary findings of a French study]. , 1985, Contraception, fertilite, sexualite.

[121]  C. la Vecchia,et al.  Reproductive and hormonal factors and breast cancer in a Northern Italian population. , 1985, International journal of epidemiology.

[122]  P. Shubik Oral contraceptives and breast cancer: laboratory evidence. , 1985, IARC scientific publications.

[123]  R. Hiatt,et al.  Exogenous estrogen and breast cancer after bilateral oophorectomy , 1984, Cancer.

[124]  M. Pike,et al.  BREAST CANCER IN YOUNG WOMEN AND USE OF ORAL CONTRACEPTIVES: POSSIBLE MODIFYING EFFECT OF FORMULATION AND AGE AT USE , 1983, The Lancet.

[125]  R. Doll,et al.  Oral contraceptives and breast cancer: final report of an epidemiological study. , 1983, British Journal of Cancer.

[126]  B. Hulka Oral contraceptives. The good news. , 1983, JAMA.

[127]  E. Trapido A prospective cohort study of oral contraceptives and breast cancer. , 1981, Journal of the National Cancer Institute.

[128]  B. Henderson,et al.  A case-control study of menopausal estrogen therapy and breast cancer. , 1980, JAMA.

[129]  J. Kelsey A review of the epidemiology of human breast cancer. , 1979, Epidemiologic reviews.

[130]  Geil Rg,et al.  FDA studies of estrogen, progestogens, and estrogen/progestogen combinations in the dog and monkey. , 1977 .

[131]  G. Beebe,et al.  Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki, 1950-69. , 1977, Journal of the National Cancer Institute.

[132]  C. Brooks,et al.  17beta-oestradiol and Enovid mammary tumorigenesis in C3H/HeJ female mice: counteraction by concurrent 2-bromo-alpha-ergocryptine. , 1977, British Journal of Cancer.

[133]  R. Geil,et al.  FDA studies of estrogen, progestogens, and estrogen/progestogen combinations in the dog and monkey. , 1977, Journal of toxicology and environmental health.

[134]  Dickey Rp,et al.  Progestational potency of oral contraceptives. , 1976 .

[135]  S. Stone,et al.  Progestational potency of oral contraceptives. , 1976, Obstetrics and gynecology.

[136]  A. Zucker CURABILITY OF BREAST CANCER , 1975, The Lancet.

[137]  S. Shulman,et al.  Letter: Transfer-factor therapy of chronic active hepatitis. , 1974, Lancet.

[138]  G. Rusten,et al.  Infiltrating duct carcinoma of the mammary gland of a rhesus monkey after administration of an oral contraceptive: a preliminary report. , 1972, Journal of the National Cancer Institute.

[139]  B. Macmahon,et al.  Breast cancer in an area of high parity: São Paulo, Brazil. , 1971, Cancer research.

[140]  C. Lowe,et al.  Breast cancer and reproductive history of women in South Wales. , 1970, Lancet.

[141]  B. Baker,et al.  Effect of long-term treatment with norethynodrel on A-J and C3H-HeJ mice. , 1969, Endocrinology.

[142]  L. Williams A 1 percent risk. , 1968, Lancet.

[143]  M. Kelly The postoperative chest. , 1964, Lancet.